Antonio Serrano
Overview
Explore the profile of Antonio Serrano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
1627
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sousa J, Serrano A, Nave A, Mascarenhas V, Nogueira P, Gamelas J, et al.
World Neurosurg
. 2023 Apr;
175:e809-e817.
PMID: 37068606
Objective: To determine and compare pelvic and lumbosacral reference parameters with computed tomography in patients with low back pain (LBP) and a control group of asymptomatic patients to provide quantification...
12.
Brandler T, Zhou F, Liu C, Serrano A, Sun W, Nikiforov Y, et al.
Thyroid
. 2023 Apr;
33(6):715-723.
PMID: 37014083
An increasing amount of data is being published, which risk-stratify thyroid tumors according to genetic signatures and histological morphology. Typically, follicular patterned lesions have been shown to harbor -like mutations...
13.
Ordner J, Flaifel A, Serrano A, Graziano R, Melamed J, Deng F
Am J Clin Pathol
. 2023 Mar;
160(1):35-40.
PMID: 36897217
Objectives: To determine the prognostic significance of the maximum allowable percentage of Gleason pattern 4 (GP4) at prostate biopsy compared with adverse pathology observed at radical prostatectomy (RP) to expand...
14.
Fernandes T, Mariscal M, Serrano A, Segorbe D, Fernandez-Acero T, Martin H, et al.
mBio
. 2023 Mar;
14(2):e0028523.
PMID: 36861989
Mitogen-activated protein kinases (MAPKs) regulate a variety of cellular processes in eukaryotes. In fungal pathogens, conserved MAPK pathways control key virulence functions such as infection-related development, invasive hyphal growth, or...
15.
Hasani Zadeh P, G Fermoso F, Collins G, Serrano A, Mills S, Abram F
Ecotoxicol Environ Saf
. 2023 Feb;
252:114604.
PMID: 36758509
Harnessing microbial capabilities for metal recovery from secondary waste sources is an eco-friendly and sustainable approach for the management of metal-containing wastes. Soluble microbial products (SMP) and extracellular polymeric substances...
16.
Jazmati D, Brualla L, Littooij A, Webber B, Dieckmann K, Janssens G, et al.
Radiother Oncol
. 2023 Jan;
181:109464.
PMID: 36640946
Background And Purpose: To establish an international quality standard for contouring and planning for high-risk neuroblastoma within the prospective High-Risk Neuroblastoma Study 2 of SIOP-Europe-Neuroblastoma (SIOPEN HR-NBL2), which includes a...
17.
Cubero-Cardoso J, Maluf Braga A, Trujillo-Reyes A, Alonso-Segovia G, Serrano A, Borja R, et al.
J Environ Manage
. 2022 Nov;
326(Pt B):116783.
PMID: 36435128
According to recent studies, the anaerobic digestion of strawberry extrudate is a promising option with potential in the berry industry biorefinery. However, the lack and/or unbalance of concentrations of metals...
18.
Ayuso B, Lalueza A, Arrieta E, Romay E, Marchan-Lopez A, Garcia-Pais M, et al.
Respir Res
. 2022 Nov;
23(1):323.
PMID: 36419130
Background: Influenza viruses cause seasonal epidemics worldwide with a significant morbimortality burden. Clinical spectrum of Influenza is wide, being respiratory failure (RF) one of its most severe complications. This study...
19.
Serrano M, Espinosa G, Serrano A, Cervera R
Autoimmun Rev
. 2022 Oct;
21(12):103206.
PMID: 36195247
Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic. Most COVID-19 patients are asymptomatic or have flu-like symptoms. However, around 15% of the patients may have severe disease, including...
20.
Naranjo L, Stojanovich L, Djokovic A, Andreoli L, Tincani A, Maslinska M, et al.
Front Immunol
. 2022 Sep;
13:957201.
PMID: 36172349
Background: Antiphospholipid syndrome (APS) is a multisystemic autoimmune disorder characterized by thrombotic events and/or gestational morbidity in patients with antiphospholipid antibodies (aPL). In a previous single center study, APS-related clinical...